The Food and Drug Administration, Centers for Disease Control and Prevention and Centers for Medicare & Medicaid Services today launched the Tri-Agency Task Force for Emergency Diagnostics, which will work to rapidly develop and deploy diagnostic tests to clinical and public laboratories in an emergency. “Timely implementation of [emergency use authorization] diagnostic assays in the U.S. health care system is dependent upon laboratories understanding the instructions for use and applying them to the patient samples received for testing,” said Kate Goodrich, CMS chief medical officer and director of the Center for Clinical Standards and Quality. “As part of this task force, it is our goal to provide clear and consistent guidance to laboratories on the application of [Clinical Laboratory Improvement Amendments] requirements for these emergency assays.”

Related News Articles

Headline
The measles outbreak in South Carolina has increased to 876 cases, the state’s Department of Public Health reported Feb. 3. Last week, the South Carolina…
Headline
Two AHA guides offer strategies for hospitals and health systems in preparing for public health emergencies and disasters and managing cybersecurity incidents…
Headline
The National Emerging Special Pathogens Training and Education Center announced Oct. 15 that it will award $37.5 million in grants to 75 hospitals seeking to…
Headline
The Centers for Disease Control and Prevention Sept. 18 issued a health advisory on a new outbreak of Ebola in the Democratic Republic of the Congo. There are…
Headline
A JAMA study published Aug. 20 found that nearly 63% of all U.S. drug production facilities from 2019 through 2024 were in counties where a weather disaster…
Headline
The White House Aug. 13 released an executive order directing the Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness…